N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, Matthew, De Marco, Anna, Lempp, Florian A., Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex +26 more·2021·Cell
DOI 10.1016/j.cell.2021.03.028

Cited by (909)

Items 701–800 of 909

  1. Microfluidic-assisted single-cell RNA sequencing facilitates the development of neutralizing monoclonal antibodies against SARS-CoV-2
    Ziwei Wang, Amelia Siqi Huang, Lingfang Tang, Jianbin Wang, Guanbo Wang · 2024 · Lab on a Chip
  2. Genetic diversity and genomic epidemiology of SARS-CoV-2 during the first 3 years of the pandemic in Morocco: comprehensive sequence analysis, including the unique lineage B.1.528 in Morocco
    Soulandi Djorwé, Abderrahim Malki, N. Nzoyikorera, J. Nyandwi, Samuel Privat Zebsoubo, Kawthar Bellamine, Amale Bousfiha · 2024 · Access Microbiology
  3. A novel genotyping system based on site polymorphism on spike gene reveals the evolutionary pathway of porcine epidemic diarrhea virus
    Mingkai Lei, Huimin Li, Xiaoyu Chen, Xiaozhen Li, Xuexiang Yu, Shengnan Ruan, Hao Wu, Ahmed H. Ghonaim, Ziyang Yan, Wentao Li et al. · 2025 · iMetaOmics.
  4. Whole-Genome Sequences of SARS-CoV-2 Lineage B.1.525 Strains (Variant η) Detected from Patients in the Abruzzo Region (Central Italy) during Spring 2021
    Emiliano Delli Compagni, Iolanda Mangone, Barbara Bonfini, Annapia Di Gennaro, Liana Teodori, Alessandra Leone, Claudia Casaccia, Ottavio Portanti, Daniela Averaimo, Katiuscia Zilli et al. · 2021 · Microbiology Resource Announcements
  5. Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
    Camilla Tiezzi, Andrea Lorenzo Vecchi, Marzia Rossi, Davide Cavazzini, Angelo Bolchi, Diletta Laccabue, Sara Doselli, Amalia Penna, Luca Sacchelli, Federica Brillo et al. · 2023 · iScience
  6. The Relationship Between Foot Conformation, Foot Placement and Motion Symmetry in the Equine Hindlimb
    Rachel Agass, Alan M. Wilson, Renate Weller, Thilo Pfau · 2014 · Equine Veterinary Journal
  7. Broadly neutralizing antibodies against SARS-CoV-2 variants
    Linqi Zhang · 2022 · National Science Open
  8. Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate
    Manolo Fernández‐Díaz, Katherine I. Calderón, Aldo Rojas-Neyra, Vikram N. Vakharia, Ricardo Choque-Guevara, Ángela Montalván-Ávalos, Astrid Poma-Acevedo, Dora Ríos-Matos, Andrés Agurto-Arteaga, Maria De Grecia Cauti Mendoza et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Ultrafast topological data analysis reveals pandemic-scale dynamics of convergent evolution
    Michael Bleher, Lukas Hahn, Maximilian Neumann, Zachary Ardern, Juan Ángel Patiño-Galindo, Mathieu Carrière, Ulrich Bauer, Raúl Rabadán, Andreas Ott · 2021 · medRxiv
  10. A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
    Jimin Lee, Cameron Stewart, Alexandra Schaefer, Elizabeth M. Leaf, Young‐Jun Park, Daniel E. Asarnow, John M. Powers, Catherine Treichel, Davide Corti, Ralph Steven Baric et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  11. B cells imprinted by ancestral SARS-CoV-2 develop pan-sarbecovirus neutralization in immune recalls
    Xixian Chen, Ling Li, Ruiping Du, Zuowei Wang, Yunjian Li, Yi Sun, Rongrong Qin, Hualong Feng, Lin Hu, Xuanyi Chen et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Genomic surveillance of SARS-CoV-2 variants in Guangzhou, China, from April 2023 to March 2024
    Zhuoyun Li, Liya Li, Yuyi Min, Yaqing Lin, Yingfen Wen, Ruiying He, Jiaojiao Li, Quanyang Gao, Fengyu Hu, Feng Li et al. · 2025 · Infection Genetics and Evolution
  13. Cetacean coronavirus spikes highlight S glycoprotein structural plasticity
    Ruben J. G. Hulswit, Tatiana M. Shamorkina, Joline van der Lee, Floor Rosman, Lisanne S. Wetzels, Frank J. M. van Kuppeveld, Joost Snijder, Berend‐Jan Bosch, Daniel L. Hurdiss · 2026 · PLoS Pathogens
  14. Intelligent Batch Epitope Identification and Partitioning: an intelligent tool for the identification of B cell dominant epitopes
    Yun-Fei Ma, Ye Liu · 2025 · Briefings in Bioinformatics
  15. Mass production of IgY-containing tablets for COVID-19 transmission control
    Michelle Hawkins, Brian Robley, Farhang Alem, Aarthi Narayanan, Philip Larson, Jason Hull, Isabella Hajduk, Michael G. Wallach · 2025 · Scientific Reports
  16. Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery
    Luciana Conde, Debora Leite Oliveira, Gabriela Maciel, Fernando Castro, Aline Albuquerque, D. A. Rodrigues, Yare Mello, Gustavo Meira de Asis, Bárbara Gabrielle, Suyane S Ferreira et al. · 2025 · The Journal of Immunology
  17. The Enigmatic Conserved Q134-F135-N137 Triad in SARS-CoV-2 Spike Protein: A Conformational Transducer?
    Marine Lefebvre, Henri Chahinian, Nouara Yahi, Jacques Fantini · 2026 · Biomolecules
  18. Structural basis for sarbecovirus Rc-o319 spike adaptation to Rhinolophus cornutus Bat ACE2 and constraints on switching to human ACE2
    Jingjing Wang, Zexuan Li, Yong Li Jiang, Zimu Li, Hang Yuan, Chuanying Niu, Yifeng Teng, Banghui Liu, Mei Li, Min Zhou et al. · 2026 · PLoS Pathogens
  19. Implemented occupational health surveillance limits the spread of SARS-CoV-2 Omicron at the workplace
    João Silveira Moledo Gesto, Adriana Cabanelas, Bruna Farjun, Monique Cristina dos Santos, Antônio Augusto Fidalgo-Neto, Sergio N. Kuriyama, Thiago Moreno L. Souza · 2022 · Frontiers in Medicine
  20. Evaluation of Increased Antibody Titer COVID-19 after Astrazeneca Vaccination Based on the Age at UTA'45 Jakarta Vaccine Center
    Stefanus Lukas, Diana Laila Ramatillah, Yufri Aldi, Fatma Sri Wahyuni, Kashifullah Khan · 2023 · Asian Journal of Pharmaceutical Research and Health Care
  21. Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine
    Ria Lassaunière, Charlotta Polacek, Jeanette Linnea Tingstedt, Anders Fomsgaard · 2023 · Vaccine
  22. Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
    Ketaren, Natalia E, Mast, Fred D, Fridy, Peter C, Olivier, Jean Paul, Sanyal, Tanmoy, Sali, Andrej, Chait, Brian T, Rout, Michael P, Aitchison, John D · 2024 · eLife
  23. Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies
    Shahid Nawaz, Sara Janiad, Aiman Fatima, Maira Saleem, Urooj Fatima, Asad Ali · 2024 · Infectious Disorders - Drug Targets
  24. Genetic Variations in Spike Protein: Linking SARS-CoV-2 Variants to Clinical Outcomes
    Peshnyar Muhammad Atta Rashid, Gaza Farag Salih · 2023 · Molecular Genetics Microbiology and Virology
  25. Relative frequency of genomic mutations in SARS-CoV-2 recovered from southern Brazilian cases of COVID-19 through the Gamma, Delta and Omicron waves
    Micheli Filippi, Meriane Demoliner, Juliana Schons Gularte, Vyctoria Malayhka de Abreu Góes Pereira, Mariana Soares da Silva, Viviane Girardi, Alana Witt Hansen, Fernando Rosado Spilki · 2024 · Infection Genetics and Evolution
  26. Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
    Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, Brijesh Pandey, Thakur Prasad Yadav, Satarudra Prakash Singh · 2024 · MedComm – Future Medicine
  27. Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection
    Jorge Julio Cabrera, Carlos Daviña‐Núñez, Sonia Rey Cao, Leticia Rodríguez Calviño, Sergio Silva-Bea, Elena Gonzalez-Alonso, Raquel Carballo, Carmen Lameiro Vilariño, S. Cortizo, Pilar Valiño-Prieto et al. · 2024 · Scandinavian Journal of Infectious Diseases
  28. Molecular targets in SARS-CoV-2 infection: An update on repurposed drug candidates
    Dibachehr Rahmani, Ameneh Jafari, Prashant Kesharwani, Amirhossein Sahebkar · 2024 · Pathology - Research and Practice
  29. Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter study
    Kuganya Nirmalarajah, Patryk Aftanas, Shiva Barati, Emily Chien, Gloria Crowl, Amna Faheem, Lubna Farooqi, Alainna Juliette Jamal, Saman Khan, Jonathon D. Kotwa et al. · 2025 · BMC Infectious Diseases
  30. A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity
    Fernanda Ana‐Sosa‐Batiz, Shailendra Kumar Verma, Norazizah Shafee, Robyn Miller, Chris Conner, Kathryn M. Hastie, Julia Timis, Erin Maule, Michael N. Nguyen, Linda Tran et al. · 2025 · EBioMedicine
  31. Low Antibody-Dependent Enhancement of Viral Entry Activity Supports the Safety of Inactivated SARS-CoV-2 Vaccines
    Xiaofang Peng, Yuru Han, Song Xue, Yunjiao Zhou, Weiyu Jiang, Anqi Xia, Wei Wu, Yidan Gao, Fan Wu, Qiao Wang · 2025 · Vaccines
  32. Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
    Wen Shi Lee, George Taiaroa, Robyn Esterbauer, Meghan Conlan, Jessica Anne Neil, Matthew J. Gartner, Monique Smith, Mingyang Wang, Rory A. Shepherd, Thomas Tran et al. · 2025 · npj Viruses
  33. Emergence of the BA.2.87.1 lineage of SARS-CoV-2 in South Africa, a highly diverged BA.2-related lineage
    Dikeledi Kekana, Buhle Ntozini, Ryan Hisner, Mukhlid Yousif, Phindile Ntuli, Nkosenhle Ndlovu, Kerrigan McCarthy, Anele Mnguni, Boitshoko Mahlangu, Ayanda Nzimande et al. · 2025 · Virus Evolution
  34. Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization
    Anna S. Karyagina, Alexander V. Gromov, Tatyana M. Grunina, Alexander M. Lyaschuk, Maria S. Poponova, Denis A. Kleymenov, Natalia V. Strukova, Maria S. Generalova, Anna V. Ryazanova, Zoya M. Galushkina et al. · 2022 · Biochemistry (Moscow)
  35. Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: Genetic relations and vaccine strain match
    Paula Perbolianachis, Diego Ferla, Rodrigo Arce, Irene Ferreiro, Alicia Costábile, Mercedes Paz, Diego Simón, Pilar Moreno, Juan Cristina · 2022 · Virus Research
  36. The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
    Xinyi Yang, Yuqi Zhu, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao et al. · 2022 · iScience
  37. Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods
    Marion F. S. Fischer, James E. Crowe, Jens Meiler · 2022 · PLoS Computational Biology
  38. Tracking of Mutational Signature of SARS-CoV-2 Omicron on Distinct Continents and Little Difference was Found
    Shu-Yue Zheng, Yunpeng Zhang, Yuxin Liu, Wei Zhao, Xiang-Lei Peng, Yan-Peng Zheng, Yuan-Hui Fu, Jie‐mei Yu, Jinsheng He · 2023 · Viruses
  39. A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021
    Corinna Ernst, Yolanda Pires‐Afonso, Dritan Bejko, Conny Huberty, Thomas G. Dentzer, Anke K. Wienecke-Baldacchino, Eric Hugoson, Daniel Álvarez, Murielle Weydert, Anne Vergison et al. · 2023 · Geriatrics
  40. Whole Sequencing and Detailed Analysis of SARS-CoV-2 Genomes in Southeast Spain: Identification of Recurrent Mutations in the 20E (EU1) Variant with Some Clinical Implications
    María José López-Andreo, María Rosario Vicente-Romero, Enrique Bernal, INMACULADA NAVARRO-GONZÁLEZ, Francisco Salazar-Martínez, Vanesa Cánovas-Cánovas, Cristina Gil-Ortuño, María Gema Riquelme-Rocamora, Francisco Solano, Francisco Javier Ibáñez‐López et al. · 2023 · Diseases
  41. Tracking the Selective Pressure Profile and Gene Flow of SARS-CoV-2 Delta Variant in Italy from April to October 2021 and Frequencies of Key Mutations from Three Representative Italian Regions
    Alessandra Lo Presti, Angela Di Martino, Luigina Ambrosio, Luca De Sabato, Arnold Knijn, Gabriele Vaccari, Ilaria Di Bartolo, Stefano Morabito, Calogero Terregino, Alice Fusaro et al. · 2023 · Microorganisms
  42. Mechanistic study of the transmission pattern of the SARS‐CoV ‐2 omicron variant
    Ke An, Xianzhi Yang, Mengqi Luo, Junfang Yan, Peiyi Xu, Honghui Zhang, Yuqing Li, Song Wu, Arieh Warshel, Chen Bai · 2024 · Proteins Structure Function and Bioinformatics
  43. Genome data artifacts and functional studies of deletion repair in the BA.1 SARS-CoV-2 spike protein
    Miguel Álvarez-Herrera, Paula Ruiz-Rodríguez, Beatriz M. Navarro-Domínguez, João Zulaica, Brayan Grau, María Alma Bracho, Manuel Guerreiro, Cristóbal Aguilar-Gallardo, Fernando Gónzález‐Candelas, Iñaki Comas et al. · 2025 · Virus Evolution
  44. Infectivity and antigenicity of SARS-CoV-2 B.1.617 variants
    Youchun Wang, Li Zhang, Qianqian Li, Jiajing Wu, Yuanling Yu, Yue Zhang, Jianhui Nie, Ziteng Liang, Zhimin Cui, Shuo Liu et al. · 2021 · Research Square
  45. Increased frequency of recurrent in-frame deletions in new expanding lineages of SARS CoV-2 reflects immune selective pressure
    Arghavan Alisoltani, Lukasz Jaroszewski, Mallika Iyer, Arash Iranzadeh, Adam Godzik · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Defective ORF8 dimerization in delta variant of SARS CoV2 leads to abrogation of ORF8 MHC-I interaction and overcome suppression of adaptive immune response
    Armi M Chaudhari, Indra Singh, Madhvi N. Joshi, Amrutlal K. Patel, Chaitanya G. Joshi · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns
    Martín A. Rossotti, Henk van Faassen, Anh Tran, Joey G. Sheff, Jagdeep K. Sandhu, D. Duque, Melissa Hewitt, S. Wen, R. Bavananthasivam, Saina Beitari et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Introduction and community transmission of SARS-CoV-2 lineage A.2.5 in Florida with novel spike INDELS
    Sarah E. Schmedes, Taj Azarian, Eleonora Cella, Jessy Motes, Omer Tekin, James Weiss, Nancimae Miller, Jason L. Blanton · 2021 · medRxiv
  49. The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
    Juan Manuel Carreño, Ariel J. Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir I. Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta et al. · 2022 · medRxiv
  50. Validation of the RT-LAMP assay in a large cohort of nasopharyngeal swab samples shows that it is a useful screening method for detecting SARS-CoV-2 and its VOC variants
    Mireya Cisneros-Villanueva, Sugela Blancas, Alberto Cedro‐Tanda, Magdalena Ríos-Romero, Eduardo Hurtado-Córdova, Oscar Almaraz-Rojas, Diana R. Ortiz-Soriano, Víctor Álvarez-Hernández, Ivonne E. Arriaga-Guzmán, Laura Tolentino-García et al. · 2022 · medRxiv
  51. Potent and specific human monoclonal antibodies against SARS-CoV-2 Omicron variant by rapid mRNA immunization of humanized mice
    Ping Ren, Lei Peng, Zhenhao Fang, Kazushi Suzuki, Paul A. Renauer, Qianqian Lin, Meizhu Bai, Luojia Yang, Tongqing Li, Paul R. Clark et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Deep mutational scanning of whole SARS-CoV-2 spike in an inverted infection system
    Shunta Taminishi, Songling Li, Yusuke Higuchi, Yuhei Kirita, Daisuke Motooka, Yuki Ozaki, Takao Arimori, Nariko Ikemura, Yumi Itoh, Satoaki Matoba et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
    Natalia E. Ketaren, Fred David Mast, Peter C. Fridy, Jean Paul Olivier, Tanmoy Sanyal, Andrej Šali, Brian T. Chait, Michael P. Rout, John D. Aitchison · 2023 · eLife
  54. Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern
    Adonis A. Rubio, Viren A. Baharani, Bernadeta Dadonaite, Megan Parada, Morgan E. Abernathy, Zijun Wang, Yu Erica Lee, Michael R. Eso, Jennie L. Phung, Israel Ramos et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Predicting SARS-CoV-2 evolution dynamics with spatiotemporal resolution by DMS-empowered protein language model
    Sijie Yang, Xiaowei Luo, Jiejian Luo, Fanchong Jian, Yunlong Cao · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Rapid emergence of transmissible SARS-CoV-2 variants in mild community cases
    Michael A. Crone, Seran Hakki, Jie Zhou, Carolina Rosadas de Oliveira, Kieran J. Madon, Aleksandra Koycheva, Anjna Badhan, Jakob Jonnerby, Joe R Fenn, Rhia Kundu et al. · 2024 · Microbiology Spectrum
  57. Role of prior immunity in binding to spike of “future” Omicron subvariants
    Deepayan Biswas, Gokulnath Mahalingam, Rajesh Kumar Subaschandrabose, Sangeetha Priya, Rohini Ramachandran, Sevanthy Suresh, Tamil Venthan Mathivanan, Nelson Vijaykumar Balu, Kavitha Selvaraj, Arun Jose Nellickal et al. · 2024 · Indian Journal of Medical Microbiology
  58. Glycan masking of NTD loops with a chimeric RBD of the spike protein as a vaccine design strategy against emerging SARS‐CoV‐2 Omicron variants
    Hao‐Chan Hung, Boon‐Fatt Tan, Wei‐Shuo Lin, Suh‐Chin Wu · 2024 · Journal of Medical Virology
  59. Progress and prospect of SARS-CoV-2 NTD-specific antibodies
    Qi GUI, Zheng Zhang, Bin Ju · 2024 · Scientia Sinica Vitae
  60. COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic
    Yasmen Mahmoud, Amira Hathout, Radwa Abdallnasser Amen, Sara Desouky, Rawan Muhammad Shady, Heba Mohamed Fahmy · 2023 · Reviews in Medical Microbiology
  61. Structural and functional properties of the SARS-CoV-2 spike protein: Potential vaccine and drug development for COVID-19
    Reed L. Berkowitz, David A. Ostrov · 2025 · Elsevier eBooks
  62. Characterization of private mutations in the spike protein of SARS-CoV-2 correlates with viral prevalence
    Shuo Wang, Ziyang Hao, Yuhan Ding, Heng Rong, Shuo Ning, Qiao Qiao, Xiaojuan Zhu, Tina Wu, Kangchen Zhao, Liguo Zhu et al. · 2025 · BMC Infectious Diseases
  63. Cleaved versus Uncleaved: How furin cleavage reshapes the conformational landscape of SARS ‐ CoV ‐2 spike
    Natesan Mani, Raghavendran Suresh, Srirupa Chakraborty · 2025 · Protein Science
  64. Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection
    Michael W. Grunst, Wenwei Li, Walther Mothes · 2026 · Frontiers in Immunology
  65. RECUR: identifying recurrent amino acid substitutions from multiple sequence alignments
    Elizabeth H J Robbins, Yi Liu, Steven L. Kelly · 2026 · Molecular Biology and Evolution
  66. Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants
    Anastasia I. Korobkova, Irina A. Favorskaya, Inna V. Shuliakova, Anna A. Iliukhina, Daria M. Grousova, Irina A. Alekseeva, Ekaterina I. Ryabova, Artem A. Derkaev, Valentin V. Azizyan, Ilya D. Zorkov et al. · 2026 · Frontiers in Immunology
  67. A deep mutational scanning-informed protein language model predicts SARS-CoV-2 evolution dynamics with spatiotemporal resolution
    S M Yang, Xiaowei Luo, Jiejian Luo, Fanchong Jian, Y J Cao · 2026 · Nature Microbiology
  68. NTD Remodeling in the SARS-CoV-2 BA.3.2 Variant May Influence Spike Stability and Immune Escape
    Miriana Quaranta, Alessandra Ciccozzi, Francesco Branda, Leonardo Sernicola, Massimo Ciccozzi, Stefano Pascarella, Alessândra Borsetti, Fabio Scarpa · 2026 · Pathogens
  69. Structural and functional characterization of a conserved cryptic epitope on SARS-CoV-2 spike S2 subunit
    Ling Zhou, Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, Andrew P. Horton, Sophie R. Shoemaker, Elizabeth C. Gardner, John M. Powers, Daniel R. Boutz, Michael L. Mallory et al. · 2026 · PLoS Pathogens
  70. A structural and mechanistic atlas of NTD antibody neutralization and immune escape across SARS-CoV-2 prototype and its (sub-)variants
    Jianjie Zhou, Wenyu Li, Xiaoyun Wang, Junqing Sun, Shuxin Guo, Xiaoyu Rong, Zhou Tong, Lianpan Dai, William Jun Liu, Jianxun Qi et al. · 2026 · Proceedings of the National Academy of Sciences
  71. Histological Spectrum of Post Covid Debridement Tissues: Salient Histomorphological Features With Respect to Identification Fungal Elements
    Preeti Agarwal, Devanshi Brajesh Dubey, Madhu Kumar, Pratima Verma, Menka Mishra, Shalini Rawat, Damini Singh, Virendra Verma, Ravindra Kumar Garg · 2022 · Clinical Pathology
  72. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
    Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, Luise Graichen, Amy Madeleine Kempf, Inga Nehlmeier, Martin Lier, Anne Cossmann, Metodi V. Stankov, Sebastian R. Schulz et al. · 2022 · Viruses
  73. Enzima Conversora de Angiotensina 2 (ECA2) e sua susceptibilidade ao Sars-Cov-2
    Elizama de Souza Silva, Júlia Ramos, Neuza Biguinati De Barros, Rogélio Rocha Barros · 2023 · Brazilian Journal of Development
  74. Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
    Shinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, Yuko Sakai‐Tagawa, Ichiro Nakachi, Rie Baba, S. Kamimoto, Takayuki Ogura, Shigehiro Hagiwara, Hideaki Kato et al. · 2023 · iScience
  75. Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea
    Atanas Vladimirov Demirev, Kyuyoung Lee, Joon‐Yong Bae, Heedo Park, Sejik Park, Hyunbeen Kim, Jungmin Lee, Jun‐Hyung Cho, Jeong‐Sun Yang, Kyung-Chang Kim et al. · 2023 · iScience
  76. Comparative analysis of immune responses in humans infected with Alpha, Delta, and Omicron strains of SARS-CoV-2
    Mihieka Bose, Chayan Munshi · 2024 · Global Translational Medicine
  77. Epitope mapping of SARS-CoV-2 Spike protein using naturally-acquired immune responses to develop monoclonal antibodies
    Rubén López-Aladid, Leticia Bueno, Roc Farriol-Duran, Eduard Porta‐Pardo, Ruth Aguilar, Marta Vidal, Alfons Jiménez, Roberto Cabrera, Nil Vázquez, Alexandre López-Gavín et al. · 2025 · Scientific Reports
  78. Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors
    Carly R. Cabel, Briana A. Guzman, Elaheh Alizadeh, Shuaizhi Li, Cameron Holberg, Chonlarat Wichaidit, Darren A. Cusanovich, Andrew L. Paek, Gregory R. J. Thatcher, Koenraad Van Doorslaer et al. · 2025 · Frontiers in Cell and Developmental Biology
  79. Update of the epidemiological distribution of COVID-19 variants: a review article
    Thomás Cavalcanti Pires de Azevedo, Vanessa Santos Cavalcante Melo, Renata Maciel da Silva, Beatriz Guerra de Holanda Barbosa, Lucas Zloccowick de Melo Christofoletti, Giovanna Maria Correia Silva do Nascimento, Guilherme Santos Lins de Oliveira, Fabiano Timbó Barbosa, Célio Fernando de Sousa‐Rodrigues, Fernando Wagner da Silva Ramos · 2021 · Revista da Associação Médica Brasileira
  80. SARS‐CoV ‐2 Delta variant in Cartagena de Indias, Colombia, August 2021
    Steev Loyola, Jaison Torres‐Pacheco, Dacia Malambo‐García, Doris Gómez‐Camargo · 2022 · Health Science Reports
  81. Effect of Covid-19 Vaccines Against Delta Variant. A Review Article
    Mohamed Ahmed Raslan, Eslam MS, Sara AR, Nagwa A. Sabri · 2022 · Acta Scientific Pharmaceutical Sciences
  82. Impact of COVID-19 on death anxiety in patients with anxiety spectrum disorders
    Sampurna Chakraborty, Prakriti Sinha, Alok Pratap, Basudeb Das, Prof Vikas Kumar · 2022 · Archives of Mental Health
  83. Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?
    Shima Tavakol, Hani Tavakol, Mohammad S. Alavijeh, Alexander Marcus Seifalian · 2022 · Current Pharmaceutical Design
  84. Evolving Faces of SARS-CoV-2 with the Emergence of Diverse Variants
    Rina Tilak · 2022 · JOURNAL OF COMMUNICABLE DISEASES
  85. Covariance predicts conserved protein residue interactions important for the emergence and continued evolution of SARS-CoV-2 as a human pathogen
    William Paul Robins, John J. Mekalanos · 2022 · PLoS ONE
  86. Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection
    Si-Ling Wang, Yang Wu, Yi-Zhe Wang, Zi-Hao Chen, Dong Ying, Xue Lin, Chang Liu, Min Lin, Jin-Lei Zhang, Yuhe Zhu et al. · 2022 · Journal of Virological Methods
  87. Cell Entry and Unusual Replication of SARS-CoV-2
    Nathan R. McCann, Francis Castellino · 2022 · Current Drug Targets
  88. Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals
    Ashwini Kurshan, Luke B. Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, Jonathan D. Edgeworth, Gaia Nebbia, Katie J. Doores · 2023 · Oxford Open Immunology
  89. An open debate on SARS-CoV-2's proximal origin is long overdue
    Rossana Segreto, Yuri Deigin, Kevin McCairn, Sousa, Alejandro, Dan Sirotkin, Karl M. Sirotkin, Jonathan J. Couey, Jones, Adrian, Zhang, Daoyu · 2021 · arXiv (Cornell University)
  90. Mapping Potential Antigenic Drift Sites (PADS) on SARS-CoV-2 Spike in Continuous Epitope-Paratope Space
    Nathaniel L. Miller, Thomas Clark, Rahul Raman, Ram Sasisekharan · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Unsupervised classification of SARS-CoV-2 genomic sequences uncovers hidden genetic diversity and suggests an efficient strategy for genomic surveillance
    Matteo Chiara, David Stephen Horner, Erika Ferrandi, Carmela Gissi, Graziano Pesole · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Vaccination with B.1.1.7, B.1.351 and P.1 variants protects mice from challenge with wild type SARS-CoV-2
    Fatima Amanat, Shirin Strohmeier, Philip S. Meade, Nicholas Dambrauskas, Barbara Mühlemann, Derek J. Smith, Vladimir I. Vigdorovich, D. Noah Sather, Lynda Coughlan, Florian Krammer · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Predicting spike protein NTD mutations of SARS-CoV-2 causing immune escape by molecular dynamics simulations
    Liping Zhou, Leyun Wu, Cheng Peng, Yanqing Yang, Yulong Shi, Zhijian Xu, Weiliang Zhu · 2021
  94. Divergence of Delta and Beta Variants and SARS-CoV-2 Evolved in Advanced HIV Disease into Two Serological Phenotypes
    Sandile Cele, Farina Karim, Gila Lustig, James Emmanuel San, Tandile Hermanus, Eduan Wilkinson, Jumari Snyman, Mallory P. Bernstein, Khadija Khan, Shi-Hsia Hwa et al. · 2021 · SSRN Electronic Journal
  95. Response of the benthic macroinvertebrate community to a point source in La Tordera stream (Catalonia, NE Spain)
    Jesús Ortiz Durà · 2005 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  96. Construction of a potent pan-vaccine based on the evolutionary tendency of SARS-CoV-2 spike protein
    Yongliang Zhao, Wenjia Ni, Simeng Liang, Lianghui Dong, Min Xiang, Zeng Cai, Danping Niu, Qiuhan Zhang, Dehe Wang, Yucheng Zheng et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  98. SARS-CoV-2 VOCs Immune Evasion from Previously Elicited Neutralizing Antibodies Is Mainly Driven by Lower Cross-Reactivity Due to Spike RBD Electrostatic Surface Changes
    Matheus Vitor Ferreira Ferraz, EMERSON MOREIRA, Danilo F. Coêlho, Gabriel Luz Wallau, Roberto Dias Lins · 2021 · ChemRxiv
  99. Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into broad-spectrum inhibitors through receptor blockade
    Payton A. B. Weidenbacher, Eric Waltari, Izumi de los Rios Kobara, Benjamin N. Bell, John E. Pak, Peter S. Kim · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Broadly neutralizing and protective nanobodies against diverse sarbecoviruses
    Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)